No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12

Affiliations

• ¹ Dipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
• ² Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
• ³ Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy.
• ⁴ Divisione di Ematologia, Fondazione IRCSS Policlinico San Matteo, Pavia, Italy.
• ⁵ Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine (DIMI), University of Verona, Verona, Italy.
• ⁶ Hematology and Stem Cell Transplantation Unit, Ospedale San Francesco, Nuoro, Italy.
• ⁷ Division of Hematology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
• ⁸ Division of Hematology, Hospital Saints Antonio, Biagio and Cesare Arrigo, Alessandria, Rome, Italy.
• ⁹ Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico Armando Businco, ARNAS G. Brotzu, Cagliari, Italy.
• ¹⁰ Facility of Epidemiology and Biostatistics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
• ¹¹ Hematology Section, Cosenza Hospital, Cosenza, Italy.
• ¹² Division of Hematology, Università degli Studi del Piemonte Orientale, Novara, Italy.
• ¹³ Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy.
• ¹⁴ Haematology and Medical Oncology, AORN Sant'Anna e San Sebastiano, Caserta, Italy.
• ¹⁵ Hematology Unit, Department of Medicine, University of Padova, Padua, Italy.
• ¹⁶ Hematology Unit, ARNAS Garibaldi, Catania, Italy.